Press release
15.11.2017 To the attention of interested persons EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of […]
Important notification
14.11.2017 To the attention of interested persons The Romanian Association of International Medicine Manufacturers (ARPIM) addresses European Medicines Agency (EMA) […]
Press release
03.11.2017 To the attention of interested persons Review of flupirtine-containing medicines started. download document …
Press release
01.11.2017 To the attention of interested persons EMA starts new review of hydroxyethyl-starch containing medicines. download document …
Press release
01.11.2017 To the attention of interested persons PRAC recommends further restrictions for multiple sclerosis medicine Zinbryta due to risk of […]
Press release
30.10.2017 To the attention of interested persons NAMMD position in response to recent press allegations The National Agency for Medicines […]
Important notification
17.10.2017 To the attention of interested persons Information for sponsors of clinical trials regarding the electronic submission of SUSARs to […]
Important notification
17.10.2017 To the attention of interested persons Information for marketing authorization holders (MAHs) regarding alternative arrangements for electronic submission of […]
Important notification
17.10.2017 To the attention of interested persons The NAMMD would like to inform about the organization in Romania of a […]
Press release
10.10.2017 To the attention of interested persons Countdown to launch of new EudraVigilance System: final preparations for change-over to new […]